Meeting
2018 ASCO Annual Meeting
A prospective cohort study in colorectal cancer assessing the relationship between post-surgery detection of methylated BCAT1 or IKZF1 ctDNA and risk for residual disease and survival.
Authors
David Murray
Clinical Genomics Technologies Pty Ltd., North Ryde, Australia
David Murray , Graeme P. Young , Susanne Kartin Pedersen , Philippa Rabbitt , Susan E Byrne , Kathryn J Cornthwaite , Amitesh Roy , Christos Karapetis , Erin L. Symonds
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Epidemiology/Outcomes
Clinical Trial Registration Number
12611000318987
Citation
J Clin Oncol 36, 2018 (suppl; abstr 3596)
DOI
10.1200/JCO.2018.36.15_suppl.3596
Abstract #
3596
Poster Bd #
89
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Post-treatment detection of circulating methylated BCAT1 and IKZF1 as prognostic indicators for recurrence in patients with colorectal cancer.
First Author: Graeme P. Young
Poster
2017 ASCO Annual Meeting
Circulating tumor DNA analysis before and after resection for colorectal cancer.
First Author: Erin L. Symonds
Poster
2021 ASCO Annual Meeting
Use of circulating tumor DNA in colorectal cancer patients to assess tumor burden and response to therapy: An observational study.
First Author: Erin L. Symonds
Poster
2021 ASCO Annual Meeting
Clinical performance of methylation-based liquid biopsy test COLVERA after optimization of test interpretation rules.
First Author: Zivjena Vucetic